Research

Dr. LeBrett studies how doctors treat digestive disease, and where that care falls short of the evidence.

Before medicine, she studied economics and worked as an economic consultant, and her research still uses those tools: national prescribing records, physician surveys, and cost analysis. Most of it was done at UCLA with Dr. Lin Chang. Her newest work turns to digital health.

Her papers on PubMed

Scientific communication and digital health

How doctors can share medical science on social media responsibly, and what consumer wearables can reveal about IBS.

  1. Step count and sleep measured by wearable device are associated with improved symptoms in patients with irritable bowel syndrome 

    Digestive Disease Week abstract2025

    Step counts and sleep tracked by a wearable device were linked to improved symptoms in people with IBS.

    Guan M, LeBrett WG, Cortessis R, Sohn J, Sach L, Badiee J, Chang L

  2. Commercially available wearable devices identify sex- and bowel habit subtype-specific autonomic and circadian patterns in irritable bowel syndrome (IBS) 

    Digestive Disease Week abstract2026

    Consumer wearables picked up patterns in nervous-system activity and daily body rhythms in people with IBS that differed by sex and by IBS type.

    Guan M, Mahurkar-Joshi S, Badiee J, Cortessis R, LeBrett WG, Sohn J, Sach L, Purdy E, Cooper S, Gomez L, Leibzon D, Lim S, Danieletto M, Hirten R, Chang L

  3. A framework for ethical and legal social media use among gastroenterologists 

    GI & Hepatology News2026

    A guide for gastroenterologists who post on social media: protecting patient privacy, keeping general information from becoming medical advice, disclosing paid partnerships, and avoiding misinformation.

    Desibhatla K, Rao S, Fijor J, LeBrett WG

Opioids and pain

How often opioids are prescribed for digestive disease, by whom, and to which patients.

  1. Opioid prescription patterns among US gastroenterologists from 2013 to 2017 

    Gastroenterology2020

    The share of gastroenterologists prescribing any opioid to Medicare patients fell from 75% in 2013 to 59% in 2017.

    Chen FW, LeBrett WG, Yang L, Chang L

  2. Increasing rates of opioid prescriptions for gastrointestinal diseases in the United States 

    The American Journal of Gastroenterology2021

    About one in ten US outpatient visits for a digestive condition ended with an opioid prescription, and that rate rose from 2006 to 2016, in the middle of the opioid crisis.

    LeBrett WG, Chen FW, Yang L, Chang L

  3. High opioid prescribing profiles among gastroenterologists: a nationwide analysis 

    Clinical Gastroenterology and Hepatology2022

    One in ten opioid-prescribing gastroenterologists wrote more than half of the specialty's opioid prescriptions for Medicare patients, every year from 2013 to 2017.

    LeBrett WG, Iyengar PS, Lee AH, Chen FW, Chang L

  4. Opioid prescription patterns and disparities during ambulatory encounters in patients with cirrhosis 

    Clinical Gastroenterology and Hepatology2023

    One in five outpatient visits by people with cirrhosis ended with an opioid prescription, two-thirds of them with no pain diagnosis on record. Older, male, and Black patients were more likely to get one.

    Lee AH, LeBrett WG, Benhammou J, Prause N, Chang L, Patel AA

  5. Opioid and nonopioid analgesic prescribing patterns of hepatologists for Medicare beneficiaries 

    Clinical and Translational Gastroenterology2024

    Liver specialists prescribed fewer opioids to Medicare patients from 2013 to 2017, but tramadol remained their most prescribed pain medication, and use of non-opioid alternatives did not grow.

    Iyengar P, Prause N, LeBrett WG, Lee A, Chang L, Patel A

Gut-brain and motility disorders

How IBS, gastroparesis, and related conditions are treated, with medication and with diet.

  1. Nutritional approaches for gastroparesis 

    The Lancet Gastroenterology & Hepatology2020

    A review of diet for gastroparesis, in which the stomach empties too slowly: what to change about meals, when to step up to liquid or tube feeding, and how thin the evidence for each still is.

    Limketkai BN, LeBrett WG, Lin L, Shah ND

  2. A survey of gastroenterologists in the United States on the use of central neuromodulators for treating irritable bowel syndrome 

    Alimentary Pharmacology & Therapeutics2021

    Most of the 525 gastroenterologists surveyed called gut-brain medications, such as low-dose antidepressants, important for IBS, yet prescribed them to only about a quarter of their IBS patients.

    Nulsen B, LeBrett WG, Drossman DA, Chang L

  3. Prescription pain medications for disorders of gut-brain interaction: comparing usage patterns with clinical practice recommendations 

    Neurogastroenterology & Motility2023

    A review of how pain in IBS and other gut-brain disorders is actually treated, from opioids to behavioral therapy, measured against what clinical guidelines recommend.

    LeBrett WG, Chang L

End-of-life care

Her research in medical school, at UC San Diego: what palliative care changes for people with advanced cancer, and what it costs.

  1. Effect of palliative care on aggressiveness of end-of-life care among patients with advanced cancer 

    Journal of Oncology Practice2017

    Among 6,580 Medicare patients with advanced cancer, those who saw a palliative care team were afterward about half as likely to be hospitalized, have invasive procedures, or receive chemotherapy.

    Triplett DP, LeBrett WG, Bryant AK, Bruggeman AR, Matsuno RK, Hwang L, Boero IJ, Roeland EJ, Yeung HN, Murphy JD

  2. Cost savings associated with palliative care among older adults with advanced cancer 

    American Journal of Hospice and Palliative Medicine2021

    For Medicare patients with advanced cancer, a palliative care consultation cut health care costs at the end of life by a quarter, and consultations weeks before death saved the most.

    Sheridan PE, LeBrett WG, Triplett DP, Roeland EJ, Bruggeman AR, Yeung HN, Murphy JD

Presentations

Talks and posters at scientific meetings.

Dr. LeBrett speaking at the lectern at UEG Week 2025 in Berlin, the audience in silhouette
Speaking at UEG Week 2025, Berlin.

2025

  • How to fight fake news in medicine?

    UEG Week · Plenary

2024

  • Implementation of a standardized order panel for gastrointestinal bleeding admissions

    North American Conference of Gastroenterology Fellows · Oral

  • Implementation of a standardized order panel for gastrointestinal bleeding admissions: a gastroenterology fellow-led, informatics-based quality improvement initiative

    Digestive Disease Week · Poster

  • Racial and ethnic disparities in patterns of care and healthcare costs among adults with irritable bowel syndrome in the United States

    Digestive Disease Week · Poster

2023

  • Irritable bowel syndrome with constipation: a case-based presentation

    UCLA Mellinkoff Gastroenterology and Hepatology Symposium · Oral

  • Co-management of psychiatric comorbidities during outpatient visits for gastrointestinal disease: a nationwide analysis

    Digestive Disease Week · Poster

  • Diagnosis of arterial-enteric fistula using video capsule endoscopy

    American College of Gastroenterology · Poster

  • Myxedema ascites: an uncommon presentation of hypothyroidism

    American College of Gastroenterology · Poster

2022

  • Abdominal pain and constipation in a patient with fibromyalgia

    UEG Week Postgraduate Teaching Programme · Oral

  • Determinants of outpatient opioid prescriptions for patients with cirrhosis in the United States

    Digestive Disease Week · Poster

  • The Visceral Sensitivity Index for inflammatory bowel disease (VSI-IBD): a novel measure of GI symptom-specific anxiety in patients with IBD

    Digestive Disease Week · Poster

2021

  • High opioid prescribing profiles among gastroenterologists: a nationwide analysis

    Digestive Disease Week · Poster

  • Opioid and analgesic prescribing patterns of hepatologists for Medicare beneficiaries from 2013 to 2017

    Digestive Disease Week · Poster

2020

  • Enteral nutrition therapy is associated with fewer readmissions and deaths among malnourished inpatients with inflammatory bowel disease

    Crohn's & Colitis Congress · Oral

  • Enteral nutrition therapy is associated with improved post-hospitalization outcome in inflammatory bowel disease patients

    Digestive Disease Week · Oral

  • Association of fecal microbiome with resilience in irritable bowel syndrome patients compared to healthy controls

    Digestive Disease Week · Poster

  • Factors affecting central neuromodulator use by gastroenterologists in the treatment of IBS: results of a national survey

    Digestive Disease Week · Poster

  • Gastroenterologists' prescribing patterns and comfort level vary across different classes of central neuromodulators for treatment of IBS

    Digestive Disease Week · Poster

  • Work limitation among adults with inflammatory bowel disease in the United States using a national sample representative of 2.5 million individuals

    Digestive Disease Week · Poster

2019

  • Opioid and neuromodulator prescription patterns among US gastroenterologists

    American College of Gastroenterology · Poster

2018

  • The financial burden of healthcare: patient perspectives on the impact of cost of care

    Society of General Internal Medicine, California-Hawaii · Poster

2017

  • Economic impact of palliative care among elderly cancer patients

    ASCO Palliative and Supportive Care in Oncology Symposium · Oral

  • Transient regional osteoporosis: a rare cause of hip pain

    American College of Physicians, Southern California · Poster

Grants and honors

2023
Fellowship Research Seed Grant, UCLA Division of Digestive Diseases
2021
Poster of Distinction, Digestive Disease Week
2018
Selma Silagi Award for Excellence in Aging Research, UC San Diego Stein Institute for Research on Aging
2015
Medical Student Training in Aging Research grant, American Federation for Aging Research and National Institute on Aging
2009
John G. Sobieski Award for Creative Thinking in Honors Research, Stanford Department of Economics